NCT03210857 (APNECK) is a NA clinical trial of apnea performing in Healthy Amateur Divers, sponsored by Nantes University Hospital.

Who is sponsoring NCT03210857?

NCT03210857 is sponsored by Nantes University Hospital.

What drugs are being tested in NCT03210857?

Interventions in NCT03210857: apnea performing.

What condition does NCT03210857 study?

NCT03210857 studies Healthy Amateur Divers.

Is NCT03210857 still recruiting?

NCT03210857 is currently completed. Last updated 15 August 2017.

Last reviewed 2017-08-15 · How we verify

NCT03210857: APNECK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Voluntary Neck Extension on Cerebral Blood Flow, in Breath-hold Divers Ending an Apnoea of Two Minutes or More.

Completed NA Last updated 15 August 2017

What this trial tests

NA trial testing apnea performing in Healthy Amateur Divers in 15 participants. Completed in 24 July 2017.

Timeline

10 July 2017

Primary endpoint
24 July 2017

24 July 2017

Quick facts

Lead sponsor	Nantes University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	15
Start date	10 July 2017
Primary completion	24 July 2017
Estimated completion	24 July 2017
Sites	1 location across France

Drugs / interventions tested

apnea performing

Conditions studied

Healthy Amateur Divers — all drugs for Healthy Amateur Divers →

Sponsor

Nantes University Hospital

Who can join

Adults 18 to 51, male only, with Healthy Amateur Divers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to demonstrate the effect of the voluntary neck extension in the occurrence of an increase in the pulsatility index of the right internal carotid artery in the amateur diver, realizing an apnea of two minutes or more.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Nantes University Hospital trials

Trials by the same sponsor.

NCT07278661 — Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. · Phase 2 · recruiting
NCT06681363 — Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelod · not yet recruiting
NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
NCT07490379 — Comparison of the Efficacy of Transcranial Direct Current Stimulation at Home Versus in Hospital Settings in Patients Wi · NA · not yet recruiting
NCT07423481 — Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03210857 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nantes University Hospital
Last refreshed: 15 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03210857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing